Edgen에서 VALN 배당금 데이터를 탐색해 보세요. 포트폴리오 계획을 위한 Valneva SE의 배당금 및 주가 추세에 대한 인공지능 기반 통찰력.

집

주식

VALN

VALN 재무

Valneva SE

$10.84

0.73%

$0.07

종가: Feb 18, 16:00:00 GMT-5

$11.28

3.97%

$0.43

프리마켓: Feb 19, 08:04:08 GMT-5

개요 예보 수입 배당금 재무사항

주요 통계

이전 종가

$10.77

시가

$10.84

일일 범위

$10.74 - $11.28

52주 범위

$5.42 - $12.25

거래량

5.3K

평균 거래량

18.8K

EPS(TTM)

-1.56

배당수익률

시가총액

$978.0M

Valneva SE란 무엇인가요?

Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. The company is headquartered in Saint-Herblain, Pays De La Loire and currently employs 695 full-time employees. The company went IPO on 2007-06-28. The firm's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The firm has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The firm is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.



기능

주식 및 암호화폐용 AI Copilot

자원

시장

수입

자산 및 부채 명세서

현금 흐름

연간

분기별

VALN 소득

미화 수백만 달러. 회계 연도는 2월부터 1월까지입니다.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
매출	274	169	153	361	348	110
매출 성장률 (YoY)	20%	10%	-57.99%	4%	216%	-13%
매출원가	147	98	100	324	182	46
매출총이익	127	71	52	36	165	63
판매비와관리비	126	94	95	56	70	45
연구개발 비용	119	67	56	101	168	61
영업비용	220	148	134	150	221	92
기타 비영업 수익(비용)	0	0	0	0	0	--
세전수익(EBT)	-115	-11	-98	-144	-69	-65
법인세비용	4	0	2	-1	3	0
순이익	-120	-12	-101	-143	-73	-64
순이익 성장률	-806%	-88%	-28.99%	96%	14%	6,300%
발행주(희석)	181.05	153.08	138.62	115.47	97.61	90.75
주식 변화 (YoY)	28%	10%	20%	18%	8%	-1%
EPS (희석주당이익)	-0.66	-0.08	-0.73	-1.24	-0.75	-0.71
EPS 성장률	-650%	-89%	-41%	65%	6%	3,450%
잉여현금흐름	-17	-83	-217	-271	-16	118
주당 잉여현금흐름	--	--	--	--	--	--
매출총이익률	46.35%	42.01%	33.98%	9.97%	47.41%	57.27%
영업이익률	-33.57%	-45.56%	-53.59%	-31.3%	-15.8%	-25.45%
이익률	-43.79%	-7.1%	-66.01%	-39.61%	-20.97%	-58.18%
잉여현금흐름마진	-6.2%	-49.11%	-141.83%	-75.06%	-4.59%	107.27%
EBITDA	--	-58	-65	-92	-41	-19
EBITDA 마진	--	-34.31%	-42.48%	-25.48%	-11.78%	-17.27%
D&A for EBITDA	--	19	17	21	14	9
EBIT	-92	-77	-82	-113	-55	-28
EBIT 마진	-33.57%	-45.56%	-53.59%	-31.3%	-15.8%	-25.45%
실질 세율	-3.47%	0%	-2.04%	0.69%	-4.34%	0%

Valneva SE(VALN) 가격

VALN 주가 차트